Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bob Kronemyer

Latest From Bob Kronemyer

HBW Market Executive Decisions: Sabinsa, Nutrition21, Council Of Manufacturing Association

Sabinsa founder edits selenium research book; Everwell adds Nutrition21 executives; and ACI’s Hockstad leads NAM Council of Manufacturing Associations.

Consumer Dietary Supplements

Medicinal Plant, Botanical Supply Chain Expert Brinckmann Elected ABC Board President

Josef Brinckmann has served on expert committees and panels for US Pharmacopeia, is a founding member of the board of FairWild Foundation and received American Botanical Council’s Champion Award in 2017.

Dietary Supplements Executive Changes

Israel's Kinoko Targets US With Nutrition Bars, Meat Alternatives From Mushroom-Based Fermentation

Kinoko’s unprocessed superfood is competitively priced to tofu and easily scalable. Market-ready products also allow for manufacturing sustainability, with minimal use of water and electricity, plus reduced emissions.

Dietary Supplements Sustainability

Twice Retired Herbalife CEO Johnson Returns To Helm For $1 Salary Plus Stock Incentives

Michael Johnson previously was CEO from 2003 to 2017 and from 2019 to early 2020, as well as chairman from 2007 to early 2020. Direct seller granted him an equity-based long-term incentive plan in stock appreciation rights and restricted stock units.

Dietary Supplements Executive Changes

ChromaDex Promotes Gerber To CFO

Gerber was serving as interim CFO. She has more than 20 years’ experience in investment management and investor relations and finance, including strategic planning, operational efficiency programs and capital market transactions.

Executive Changes Dietary Supplements

Perrigo Supports Hypoallergenic Infant Formula Savings Claims, Not Equivalence To Enfamil Brand

Perrigo can continue claiming its store brand hypoallergenic infant formula saves customers more than 20% compared to leading name brands while providing similar nutrition to leading brands. But meeting AAP standard doesn’t measure up as equivalent to brands, industry self-regulation group says.

Enforcement Advertising, Marketing & Sales
See All
UsernamePublicRestriction

Register